ISFR:LSE:LSE-iShares MSCI France UCITS (GBX)

ETF | Others |

Last Closing

USD 4841

Change

+18.25 (+0.38)%

Market Cap

USD 0.16B

Volume

790.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-3.05 (-1.64%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.19 (-0.98%)

USD 640.06B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.06 (-0.45%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

-3.55 (-3.26%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

-0.25 (-0.78%)

USD 259.48B
0QZO:LSE 0QZO

-1.10 (-1.21%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-0.40 (-0.27%)

USD 202.26B
0R24:LSE Intel Corp.

N/A

USD 196.14B

ETFs Containing ISFR:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.84% 85% B 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.84% 85% B 77% C+
Trailing 12 Months  
Capital Gain -0.59% 28% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.59% 26% F 40% F
Trailing 5 Years  
Capital Gain 81.12% 75% C 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 81.12% 72% C 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 10.76% 68% D+ 71% C-
Dividend Return 10.76% 67% D+ 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.67% 57% F 75% C
Risk Adjusted Return 92.18% 85% B 91% A-
Market Capitalization 0.16B 57% F 33% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike